Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4180

1.

Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.

Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.

Ann Thorac Surg. 2009 Jul;88(1):186-92; discussion 192-3. doi: 10.1016/j.athoracsur.2009.03.079.

PMID:
19559222
2.

Total number of resected lymph nodes predicts survival in esophageal cancer.

Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M.

Ann Surg. 2008 Aug;248(2):221-6. doi: 10.1097/SLA.0b013e31817bbe59.

PMID:
18650631
3.

Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.

Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, Mazumdar M, Port JL.

Ann Surg. 2008 Mar;247(3):434-9. doi: 10.1097/SLA.0b013e318163a2ff.

PMID:
18376186
4.

Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall.

Chapelier A, Fadel E, Macchiarini P, Lenot B, Le Roy Ladurie F, Cerrina J, Dartevelle P.

Eur J Cardiothorac Surg. 2000 Nov;18(5):513-8.

PMID:
11053809
5.

Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection.

Igaki H, Kato H, Tachimori Y, Sato H, Daiko H, Nakanishi Y.

Eur J Cardiothorac Surg. 2001 Jun;19(6):887-93.

PMID:
11404147
6.

Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.

Chao YK, Wu YC, Liu YH, Tseng CK, Chang HK, Hsieh MJ, Chu Y, Liu HP.

J Surg Oncol. 2010 Aug 1;102(2):158-62. doi: 10.1002/jso.21588.

PMID:
20648587
7.

Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography.

Eloubeidi MA, Wallace MB, Hoffman BJ, Leveen MB, Van Velse A, Hawes RH, Reed CE.

Ann Thorac Surg. 2001 Jul;72(1):212-9; discussion 219-20.

PMID:
11465182
8.

Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.

Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N.

Am J Surg. 2005 Jan;189(1):98-109.

PMID:
15701501
9.

Long-term results of transhiatal esophagectomy for esophageal carcinoma. A multivariate analysis of prognostic factors.

Gertsch P, Vauthey JN, Lustenberger AA, Friedlander-Klar H.

Cancer. 1993 Oct 15;72(8):2312-9.

10.

The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.

Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR.

Ann Surg. 2008 Oct;248(4):549-56. doi: 10.1097/SLA.0b013e318188c474.

PMID:
18936567
11.

Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.

Tachibana M, Kinugasa S, Dhar DK, Kotoh T, Shibakita M, Ohno S, Masunaga R, Kubota H, Kohno H, Nagasue N.

J Surg Oncol. 1999 Oct;72(2):88-93.

PMID:
10518105
12.

Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.

Schwer AL, Ballonoff A, McCammon R, Rusthoven K, D'Agostino RB Jr, Schefter TE.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):449-55. doi: 10.1016/j.ijrobp.2008.04.022. Epub 2008 Jun 4.

PMID:
18538500
13.

Survival after esophageal resection for carcinoma: the importance of the histologic cell type.

Alexiou C, Khan OA, Black E, Field ML, Onyeaka P, Beggs L, Duffy JP, Beggs DF.

Ann Thorac Surg. 2006 Sep;82(3):1073-7.

PMID:
16928541
14.

The recurrence pattern of esophageal carcinoma after transhiatal resection.

Hulscher JB, van Sandick JW, Tijssen JG, Obertop H, van Lanschot JJ.

J Am Coll Surg. 2000 Aug;191(2):143-8.

PMID:
10945357
15.

An audit of surgical outcomes of esophageal squamous cell carcinoma.

Goan YG, Chang HC, Hsu HK, Chou YP.

Eur J Cardiothorac Surg. 2007 Mar;31(3):536-44. Epub 2007 Jan 11.

PMID:
17222561
16.

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.

Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.

Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.

PMID:
18498797
17.

The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.

Waterman TA, Hagen JA, Peters JH, DeMeester SR, Taylor CR, Demeester TR.

Ann Thorac Surg. 2004 Oct;78(4):1161-9; discussion 1161-9.

PMID:
15464464
18.

Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.

Ielpo B, Pernaute AS, Elia S, Buonomo OC, Valladares LD, Aguirre EP, Petrella G, Garcia AT.

Interact Cardiovasc Thorac Surg. 2010 May;10(5):704-8. doi: 10.1510/icvts.2009.222778. Epub 2010 Feb 13.

PMID:
20154347
19.

Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.

Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR.

Cancer. 1999 Nov 1;86(9):1700-11.

PMID:
10547542
20.

[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].

Zhang HL, Liu RL, Shi YT, Wang ZC, Wang BH, Li YJ, Zhou LY, Ping YM.

Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5. Chinese.

PMID:
19950705

Supplemental Content

Support Center